Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 1.50% | 203.83 | 1.2% | $408.14m | |
| GILD | Gilead Sciences, Inc. | 1.25% | 73.69 | 0.9% | $399.40m | |
| CELG | Celgene Corporation | 1.25% | 88.29 | 1.2% | $343.37m | |
| BIIB | Biogen Inc. | 0.75% | 336.92 | 1.2% | $276.03m | |
| ILMN | Illumina, Inc. | 2.11% | 354.53 | 3.5% | $257.55m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.58% | 388.74 | 2.6% | $211.47m | |
| EXAS | Exact Sciences Corporation | -1.06% | 72.56 | 25.3% | $196.60m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.26% | 178.02 | 1.9% | $161.89m | |
| SRPT | Sarepta Therapeutics, Inc. | 1.14% | 154.09 | 16.4% | $126.29m | |
| A | Agilent Technologies, Inc. | -0.20% | 68.94 | 1.5% | $121.25m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 2.35% | 120.58 | 2.0% | $110.02m | |
| NKTR | Nektar Therapeutics | 2.06% | 59.51 | 5.6% | $97.94m | |
| ALNY | Alnylam Pharmaceuticals, Inc | 1.86% | 95.09 | 9.7% | $97.60m | |
| BMRN | BioMarin Pharmaceutical Inc. | 1.58% | 99.70 | 4.4% | $92.11m | |
| INCY | Incyte Corporation | 1.31% | 67.90 | 2.5% | $88.86m |
Company Profile
Fibrocell Science, Inc. is an autologous cell and gene therapy company, which engages in translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. Its clinical and pre-clinical programs include treatments for restrictive burn scars, vocal cord scars, and acne scars. The company was founded on September 1, 2009 and is headquartered in Exton, PA.